CIK 0001668397 · Large accelerated filer
Medpace Holdings, Inc.
Sign in to watch- Ticker
- MEDP
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320434904
- Phone
- (513) 579-9911
- Business address
- 5375 MEDPACE WAY, CINCINNATI, OH, 45227
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $191,774,429
- in 16 filings
Net −$191,774,429. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-20 | Brady Kevin M. CFO & Treasurer | Option exercise · Employee Stock Option (Right to Buy) | −3,400 | 3,403 | ||
| 2026-08-20 | Troendle August J. President & CEO | Sale | −27,174 | $618.79 | $16.8M | 561,195 |
| 2026-08-19 | Troendle August J. President & CEO | Sale | −15,609 | $606.47 | $9.5M | 588,369 |
| 2026-08-19 | Carley Brian T Director | Sale | −5,000 | $608.63 | $3.0M | 27,825 |
| 2026-08-19 | DAVENPORT FRED B JR Director | Option exercise | +1,903 | $133.87 | $255K | 5,401 |
| 2026-08-19 | DAVENPORT FRED B JR Director | Option exercise | +3,858 | $84.36 | $325K | 9,259 |
| 2026-08-19 | DAVENPORT FRED B JR Director | Option exercise | +1,822 | $164.68 | $300K | 11,081 |
| 2026-08-19 | DAVENPORT FRED B JR Director | Sale | −7,283 | $606.15 | $4.4M | 3,798 |
| 2026-08-19 | DAVENPORT FRED B JR Director | Option exercise · Stock Option (Right to Buy) | −1,903 | 0 | ||
| 2026-08-19 | DAVENPORT FRED B JR Director | Option exercise · Stock Option (Right to Buy) | −3,858 | 0 | ||
| 2026-08-19 | DAVENPORT FRED B JR Director | Option exercise · Stock Option (Right to Buy) | −1,822 | 0 | ||
| 2026-08-13 | Troendle August J. President & CEO | Sale | −458 | $600.39 | $275K | 603,978 |
| 2026-08-12 | Troendle August J. President & CEO | Sale | −11,366 | $601.53 | $6.8M | 604,436 |
| 2026-08-11 | McCarthy Cornelius P. III Director | Sale | −1,140 | $605.37 | $690K | 12,275 |
| 2026-08-11 | Troendle August J. President & CEO | Sale | −17,610 | $605.11 | $10.7M | 615,802 |
| 2026-08-10 | Troendle August J. President & CEO | Sale | −5,534 | $601.53 | $3.3M | 633,412 |
| 2026-08-07 | McCarthy Cornelius P. III Director | Option exercise | +3,858 | $84.36 | $325K | 14,210 |
| 2026-08-07 | McCarthy Cornelius P. III Director | Sale | −795 | $585.07 | $465K | 13,415 |
| 2026-08-07 | McCarthy Cornelius P. III Director | Option exercise · Stock Option (Right to Buy) | −3,858 | 0 | ||
| 2026-07-28 | BURWIG SUSAN E Exec. VP, Operations | Sale | −7,500 | $600.00 | $4.5M | 62,984 |
Page 3 of 10 · 196 trades